| sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ... EMBO molecular medicine 8 (5), 466-476, 2016 | 511 | 2016 |
| β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer SP Tenbaum, P Ordóñez-Morán, I Puig, I Chicote, O Arqués, S Landolfi, ... Nature medicine 18 (6), 892-901, 2012 | 442 | 2012 |
| Global and regional gray matter reductions in ADHD: a voxel-based morphometric study S Carmona, O Vilarroya, A Bielsa, V Tremols, JC Soliva, M Rovira, ... Neuroscience Letters 389 (2), 88-93, 2005 | 377 | 2005 |
| Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum AL Benedet, M Milà-Alomà, A Vrillon, NJ Ashton, TA Pascoal, F Lussier, ... JAMA neurology 78 (12), 1471-1483, 2021 | 357 | 2021 |
| The expression of GLP‐1 receptor mRNA and protein allows the effect of GLP‐1 on glucose metabolism in the human hypothalamus and brainstem E Alvarez, MD Martínez, I Roncero, JA Chowen, B García‐Cuartero, ... Journal of neurochemistry 92 (4), 798-806, 2005 | 337 | 2005 |
| Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ … M Suárez‐Calvet, TK Karikari, NJ Ashton, J Lantero Rodriguez, ... EMBO molecular medicine 12 (12), e12921, 2020 | 325 | 2020 |
| Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease M Milà-Alomà, NJ Ashton, M Shekari, G Salvadó, P Ortiz-Romero, ... Nature medicine 28 (9), 1797-1801, 2022 | 324 | 2022 |
| Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum M Milà‐Alomà, G Salvadó, JD Gispert, N Vilor‐Tejedor, O Grau‐Rivera, ... Alzheimer's & Dementia 16 (10), 1358-1371, 2020 | 186 | 2020 |
| Influence of the normalization template on the outcome of statistical parametric mapping of PET scans JD Gispert, J Pascau, S Reig, R Martinez-Lazaro, V Molina, ... Neuroimage 19 (3), 601-612, 2003 | 172 | 2003 |
| Biodistribution of Amino-Functionalized Diamond Nanoparticles. In Vivo Studies Based on 18F Radionuclide Emission. S Rojas, JD Gispert, R Martin, S Abad, C Mench n, D Pareto, VM V ctor, ... ACS nano, 2011 | 170 | 2011 |
| Ventro-striatal reductions underpin symptoms of hyperactivity and impulsivity in attention-deficit/hyperactivity disorder S Carmona, E Proal, EA Hoekzema, JD Gispert, M Picado, I Moreno, ... Biological psychiatry 66 (10), 972-977, 2009 | 165 | 2009 |
| Imaging Brain Inflammation with [11C]PK11195 by PET and Induction of the Peripheral-Type Benzodiazepine Receptor after Transient Focal Ischemia in Rats S Rojas, A Martín, MJ Arranz, D Pareto, J Purroy, E Verdaguer, J Llop, ... Journal of Cerebral Blood Flow & Metabolism 27 (12), 1975-1986, 2007 | 164 | 2007 |
| The ALFA project: a research platform to identify early pathophysiological features of Alzheimer's disease JL Molinuevo, N Gramunt, JD Gispert, K Fauria, M Esteller, C Minguillon, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 2 (2 …, 2016 | 158 | 2016 |
| Synthesis and In Vivo Evaluation of the Biodistribution of a 18F-Labeled Conjugate Gold-Nanoparticle-Peptide with Potential Biomedical Application S Guerrero, JR Herance, S Rojas, JF Mena, JD Gispert, GA Acosta, ... Bioconjugate chemistry 23 (3), 399-408, 2012 | 147 | 2012 |
| Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers G Salvadó, JL Molinuevo, A Brugulat-Serrat, C Falcon, O Grau-Rivera, ... Alzheimer's research & therapy 11, 1-12, 2019 | 140 | 2019 |
| Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease R Cacciaglia, JL Molinuevo, C Falcón, A Brugulat-Serrat, ... Alzheimer's & Dementia 14 (7), 902-912, 2018 | 130 | 2018 |
| Randomized phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer (PREMER): a GICOR-GOECP-SEOR study N Rodríguez de Dios, F Couñago, M Murcia-Mejía, M Rico-Oses, ... Journal of Clinical Oncology 39 (28), 3118-3127, 2021 | 122 | 2021 |
| Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease JD Gispert, M Suárez-Calvet, GC Monté, A Tucholka, C Falcon, S Rojas, ... Alzheimer's & Dementia 12 (12), 1259-1272, 2016 | 116 | 2016 |
| Quantification of amyloid PET for future clinical use: a state-of-the-art review HG Pemberton, LE Collij, F Heeman, A Bollack, M Shekari, G Salvadó, ... European journal of nuclear medicine and molecular imaging 49 (10), 3508-3528, 2022 | 113 | 2022 |
| Enhanced neural activity in frontal and cerebellar circuits after cognitive training in children with attention‐deficit/hyperactivity disorder E Hoekzema, S Carmona, V Tremols, JD Gispert, M Guitart, J Fauquet, ... Human brain mapping 31 (12), 1942-1950, 2010 | 111 | 2010 |
Marc Suárez-CalvetBarcelonaBeta Brain Research CenterVahvistettu sähköpostiosoite verkkotunnuksessa barcelonabeta.org